Search Results 161-170 of 12354 for Multiple myeloma red flag
... multiple myeloma. Cohorts of patients will receive multiple ascending doses of intravenous DFRF4539A every 3 weeks or weekly. Patients exhibiting acceptable ...
Learn about this cancer that forms from white blood cells called plasma cells. Treatments include medicines and bone marrow transplant.
Smoldering multiple myeloma; Amyloidosis; Macroglobulinemia; Monoclonal gammopathy-associated conditions including C1-esterase inhibitor deficiency, ...
A Study Of Atezolizumab Alone Or Combined With Immunomodulatory Drug And/or Daratumumab In Multiple Myeloma Patients · Share · Facebook · Twitter.
About this study. The purpose of the study is to compare once-weekly carfilzomib dosing in combination with dexamethasone to twice-weekly carfilzomib dosing ...
Multiple myeloma (MM) is a blood cancer that affects a type of white cell called plasma cell. It mainly affects older individuals and has an average age at ...
Project 1 in the Mayo Clinic Multiple Myeloma SPORE studies underlying mechanisms of resistance to T cell-directed therapies.
This phase II trial studies how well carfilzomib and dexamethasone work in treating patients with multiple myeloma who previously underwent a stem cell ...
Three cores in the Mayo Clinic Multiple Myeloma SPORE help manage infrastructure, data, project oversight, biospecimens and clinical trials.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.